Concepedia

Gaëlle Gillet

GG

Statistics

Publications

5

Citations

576

H-Index

5

Active since

2018

Affiliations

UCB Pharma (Belgium)(Current)

Harvard University

Harvard Stem Cell Institute

Broad Institute

Gaëlle Gillet is an author at UCB Pharma (Belgium) specializing in life sciences, inflammatory signaling, and neuroinflammation.

ORCID

Publications per year

2018–2024

5

Publications

5

C9orf72 suppresses systemic and neural inflammation induced by gut bacteria

Aaron Burberry, Michael F. Wells, Francesco Limone et al. · Nature · 2020 · 343 citations · Full text

, , +14

A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target

Prashant K. Srivastava, Jonathan van Eyll, Patrice Godard et al. · Nature Communications · 2018 · 106 citations · Full text

, , +13

Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease

James Keaney, Julien Gasser, Gaëlle Gillet et al. · Journal of Neuroimmune Pharmacology · 2019 · 99 citations · Full text

, , +17

Myeloid and lymphoid expression of <i>C9orf72</i> regulates IL-17A signaling in mice

Francesco Limone, Alexander Benavides Couto, Jinyuan Wang et al. · Science Translational Medicine · 2024 · 15 citations · Full text

, , +17

Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS

Marie‐Laure Clénet, James Keaney, Gaëlle Gillet et al. · Frontiers in Immunology · 2023 · 13 citations · Full text

, , +17

1–5 of 5